| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 03/01/2007 | WO2006047528A3 Pyrazolobenzamides and derivatives as factor xa inhibitors |
| 03/01/2007 | US20070049633 p38 MAP kinase inhibitors and methods for using the same |
| 03/01/2007 | US20070049632 antidiabetic agents; (4S,7R)-1-Benzyl-7,8,8-trimethyl-2-phenyl-1,2,4,5,6,7-hexahydro-4,7-methano-indazol-3-one; treating metabolic disorder comprises diabetes, obesity or metabolic syndrome, type II diabetes |
| 03/01/2007 | US20070049629 Non-Steroidal Antiandrogens |
| 03/01/2007 | US20070049495 1-Methyl, 3-trifluoromethyl,4-(2-(4-(tert-butylpyrazol-1-yl),2-cyano,1-tert-butylcarbonyloxy)ethylene)-pyrazole; agriculture; preventing the attachment of aquatic organisms to boats, construction materials, heat excangers; coolants; water supply systems; engineering plants; reservoirs; marine/underwater |
| 03/01/2007 | DE102005039066A1 New indazole squaric acid compounds are checkpoint kinase-1 modulators, useful to treat or prevent e.g. cancer, diabetes mellitus, microangiopathy, glaucoma, cataract, bacterial infections, cell aging, stress, and arteriosclerosis |
| 03/01/2007 | CA2620257A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | CA2620254A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | CA2619851A1 3-oxo-indazole-squaric acid derivatives |
| 03/01/2007 | CA2619365A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators |
| 03/01/2007 | CA2619101A1 Immunosuppressant compounds and compositions |
| 02/28/2007 | EP1757590A1 Piperazinylalkylpyrazole derivatives useful as selective T-type calcium channel blockers and preparation method thereof |
| 02/28/2007 | EP1757589A1 Amorphous phase of a substituted pyrazoline, its preparation and use as medicament |
| 02/28/2007 | EP1757588A1 Polymorph of N-Piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-1H-pyrazole-3-carboxamide and its use as a cannabinoid receptor modulator |
| 02/28/2007 | EP1757587A1 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 02/28/2007 | EP1756091A1 Non nucleoside reverse transcriptase inhibitors |
| 02/28/2007 | EP1756078A1 Phenylsulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 02/28/2007 | EP1756076A1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 02/28/2007 | EP1756065A1 Anti-cytokine heterocyclic compounds |
| 02/28/2007 | EP1756064A2 Pyrazole derivatives, compositions containing such compounds and methods of use |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1756058A1 Histamine-3 receptor antagonists |
| 02/28/2007 | EP1756054A1 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor |
| 02/28/2007 | EP1756029A1 Novel compounds, the preparation and the use thereof for a regiospesific synthesis of perfluor(alkyl) group heterocycles |
| 02/28/2007 | EP1626962B1 Benzamide inhibitors of the p2x7 receptor |
| 02/28/2007 | EP1309592B9 Substituted pyrazoles |
| 02/28/2007 | EP1102753B1 Pyrazoles as estrogen receptor modulators |
| 02/28/2007 | CN1922180A Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 02/28/2007 | CN1922162A Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 02/28/2007 | CN1922161A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics |
| 02/28/2007 | CN1922160A Compounds |
| 02/28/2007 | CN1922159A Benzamide derivatives and their use as glucokinase activating agents |
| 02/28/2007 | CN1922150A Indazole derivatives and pharmaceutical compositions containing them |
| 02/28/2007 | CN1922149A Pyrrole and pyrazole daao inhibitors |
| 02/28/2007 | CN1922148A Pyrazole derivatives as protein kinase modulators |
| 02/28/2007 | CN1919845A Compound containing tetrazine polynitrobenzene and synthesis method thereof |
| 02/28/2007 | CN1919838A Alpha-cyano-N-benzylpyrazoamide compound, preparation method and pest control agent thereof as active component |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/27/2007 | US7183307 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/27/2007 | US7183306 Pyrazole derivatives |
| 02/27/2007 | US7183296 Anti-HIV pyrazole derivatives |
| 02/22/2007 | WO2007021966A1 Pyrazole compounds that modulate hsp90 activity |
| 02/22/2007 | WO2007021873A2 Preparation of 4,5-diamino-1-(substituted)-pyrazole and acid addition salts thereof |
| 02/22/2007 | WO2007021711A2 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/22/2007 | WO2007020986A1 Substituted pyrazolecarboxylic acid anilide derivative or salt thereof, intermediate thereof, agent for agricultural and horticultural use, and use thereof |
| 02/22/2007 | WO2007020194A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/22/2007 | WO2007020098A1 Method for producing substituted pyrazoles |
| 02/22/2007 | WO2007019933A1 1-acyldihydropyrazol derivatives |
| 02/22/2007 | WO2005089511A3 Novel pharmaceutical forms, and methods of making and using the same |
| 02/22/2007 | US20070043512 Therapeutic and prophylactic compositions and uses therefor |
| 02/22/2007 | US20070043220 {2-Methyl-4-[3-methyl-1-(4-trifluoromethyl-phenyl)-1H-pyrazol-4-ylmethylsulfanyl]-phenoxy}-acetic acid; diabetes mellitus, Metabolic Syndrome, atherosclerosis, cardiovascular diseases,Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension |
| 02/22/2007 | US20070043011 Substituted benzanilide compound and noxious organism controlling agent |
| 02/22/2007 | US20070042996 N-alkynyl-2-(substituted aryloxy) alkylthioamine derivatives as fungicides |
| 02/22/2007 | DE102005038537A1 1-Acyldihydropyrazolderivate 1 Acyldihydropyrazolderivate |
| 02/22/2007 | CA2619780A1 Method for producing substituted parasols |
| 02/22/2007 | CA2619039A1 1-acyldihydropyrazole derivatives |
| 02/22/2007 | CA2619010A1 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/22/2007 | CA2618377A1 Pyrazole compounds that modulate hsp90 activity |
| 02/22/2007 | CA2618340A1 Piperidine and piperazine derivatives as p2x3 antagonists |
| 02/21/2007 | EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 02/21/2007 | EP1753763A2 Indazole and indolone derivatives and their use as pharmaceuticals |
| 02/21/2007 | EP1753726A1 Method for producing 1,5-diphenylpyrazole carboxylic acid derivatives |
| 02/21/2007 | EP1753724A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases |
| 02/21/2007 | EP1551798B1 Novel sulphones for inhibition of gamma secretase |
| 02/21/2007 | EP1000025B1 Substituted naphthopyrans |
| 02/21/2007 | CN1918129A Therapeutic agent |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
| 02/21/2007 | CN1917763A N-(2-(hydroxymethyl) phenyl)-1h-pyrazole-4-carboxamide derivatives and related compounds as microbicidal active ingredients for phyto-protection and the protection of materials |
| 02/21/2007 | CN1915978A Crystal form of lonidamine, preparation method, and composition of containing the crystal form |
| 02/21/2007 | CN1915977A Chlorine-fipronil, prepartion and application |
| 02/20/2007 | US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/15/2007 | WO2007018232A1 Monoazo compound, ink composition, and colored object |
| 02/15/2007 | WO2007018226A1 Prophylactic and/or therapeutic agent for corneal disorder |
| 02/15/2007 | WO2007017509A1 Compounds for the treatment of alzheimer's disease |
| 02/15/2007 | WO2007017450A1 Fungicidal n-[2-(haloalkoxy)phenyl]heteroarylcarboxamides |
| 02/15/2007 | WO2007017124A1 Amorphous phase of a substituted pyrazoline, its preparation and use as medicament |
| 02/15/2007 | WO2007017093A1 Substituted 2-benzyloxy-benzoic acid amide derivatives |
| 02/15/2007 | WO2007017092A1 Substituted 4-benzyloxy-benzoic acid amide derivatives |
| 02/15/2007 | WO2006136829A3 Pyrazole derivatives and their use as pka and pkb modulators |
| 02/15/2007 | US20070037987 Preparation of 4,5-diamino-1-(substituted)-pyrazole and acid addition salts thereof |
| 02/15/2007 | US20070037858 Hexyl carboxanilides and their use for controlling undesirable micro-organisms |
| 02/15/2007 | US20070037808 Anti-inflammatory medicaments |
| 02/15/2007 | US20070037802 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/15/2007 | US20070037772 Pyrazolidinol compounds |
| 02/15/2007 | DE19826669B4 Verfahren zur Herstellung von Pyrazolen A process for the preparation of pyrazoles |
| 02/15/2007 | DE102005037499A1 Pyrazolderivate Pyrazole derivatives |
| 02/15/2007 | CA2618019A1 Compounds for the treatment of alzheimer's disease |
| 02/14/2007 | EP1751139A2 Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| 02/14/2007 | EP1751115A1 Theramutein modulators |
| 02/14/2007 | EP1751113A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 02/14/2007 | EP1751112A2 Anthranilamide insecticides |
| 02/14/2007 | EP1750698A2 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes |
| 02/14/2007 | EP1750696A2 Resistance-repellent retroviral protease inhibitors |
| 02/14/2007 | EP1533292B1 Dibenzylamine compound and medicinal use thereof |
| 02/14/2007 | EP1483438B1 Aqueous liquid formulations of pyrazoline brighteners |
| 02/14/2007 | EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 02/14/2007 | CN1914205A Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |